Summary
The radiotherapeutic management of Hodgkin’s disease is approaching optimization with appreciation of the need to extend treatment to include major portions of the axial lymphatic chain. Unequivocal evidence now exists that “prophylactic” irradiation of occultly diseased sites can not only reduce the incidence of relapse but also materially improve survival. Further major advances in the therapy of Hodgkin’s disease will depend upon the integration of chemotherapy and radiotherapy in those presentations having a significant risk of clinically undetectable extranodal spread.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gilbert, R.: Radiotherapy in Hodgkin’s disease. Amer. J. Roentgenol. 41, 198 (1939).
Jelliffe, A. M., Thomson, A. D.: The prognosis in Hodgkin’s diseaese. Brit. J. Cancer 9, 21 (1955).
Scott, R. M., Brizel, H. E.: Time-dose relationships in Hodgkin’s disease. Radiology 82, 1043 (1964).
Kaplan, H. S.: Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin’s disease. Cancer Res. 26, 1221 (1966).
Landberg, T., Forslo, H.: Radiosensitivity of mediastinal lymphomas in Hodgkin’s disease treated with split-course radiotherapy. Acta Radiol. (Stockh.) 9, 177 (1970).
JOHNSON, R. E.: Total nodal irradiation of Hodgkin’s disease: Technical and clinical aspects. In: Textbook of Radiotherapy (FLETCHER, G., Ed.). Philadelphia: Lea & Feibiger.
Johnson, R. E., Glover, M. G., Marshall, S. K.: Results of radiation therapy and implications for the clinical staging of Hodgkin’s disease. Cancer Res. 31, 1834 (1971).
Kaplan, H. S.: Prognostic significance of the relapse-free interval after radiotherapy in Hodgkin’s disease. Cancer (Philad.) 22, 1131 (1968).
Seydel, H. G., Wizenberg, M. J., Bloedorn, F. G.: Results of radiotherapeutic treatment of relapsing Hodgkin’s disease. Cancer (Philad.) 23, 1033 (1969).
Moore, M. R., Bull, J. M., Jones, S. E., Rosenberg, S. A., Kaplan, H. S.: Combined radiotherapy and chemotherapy in the treatment of Hodgkin’s disease. Ann. intern. Med. 77, 1 (1972).
De Vita, V. T., Johnson, R. E.: Unpublished data.
Leukemia Cooperative Group B: Unpublished data.
Johnson, R. E., Thomas, L. B., Chretien, P.: Correlation between clinico-histologic staging and extranodal relapse in Hodgkin’s disease. Cancer (Philad.) 25, 1071 (1970).
VAN DER Werf-messing, B.; Reticulum cell sarcoma and lymphosarcoma. A retrospective study of potential survival in Loco-regional disease. Europ. J. Cancer 4, 549 (1968).
Wang, C. C, Fleischli, D. J.: Primary reticulum cell sarcoma of bone. Cancer (Philad.) 22, 994 (1968).
Banfi, A., Bonadonna, G., Ricci, S. B., Milani, F., Molinari, R., Monfardini, S., Zucali, R.: Malignant lymphomas of Waldeyer’s ring: Natural history and survival after radiotherapyBrit. med. J. 1972 III, 140.
Johnson, R. E.: Evaluation of fractionated total body irradiation in patients with leukemia and disseminated lymphomas. Radiology 86, 1085 (1966).
Johnson, R. E., O’conor, G. T., Levin, D.: Primary management of advanced lymphosarcoma with radiotherapy. Cancer (Philad.) 25, 787 (1970).
Johnson, R. E.: Remission induction and remission duration with primary radiotherapy in advanced lymphosarcoma. Cancer (Philad.) 29, 1473 (1972).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Johnson, R.E. (1974). Radiotherapy of Hodgkin’s Disease and Malignant Lymphomas. In: Musshoff, K. (eds) Diagnosis and Therapy of Malignant Lymphoma. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 46. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80829-6_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-80829-6_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80831-9
Online ISBN: 978-3-642-80829-6
eBook Packages: Springer Book Archive